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A B S T R A C T
While gray matter (GM) anomalies have been reported for attention-deﬁcit/hyperactivity disorder (ADHD),
investigating their associations with cognitive deﬁcits and individual symptom domains can help pinpoint the
neural underpinnings critical for the pathology of ADHD, particularly the persist form of ADHD. In this work, we
performed both independent component analysis and voxel-based morphometry analysis on whole brain GM of
486 adults including 214 patients, 96 unaﬀected siblings, and 176 healthy controls, in relation to cognition and
symptoms. Independent component analysis revealed that higher GM volume in inferior semilunar lobule, in-
ferior frontal gyri, and superior and middle frontal gyri was associated with better working memory perfor-
mance, and lower GM volume in cerebellar tonsil and culmen was associated with more severe inattention
symptoms. Consistently, voxel-based morphometry analysis showed that higher GM volume in multiple regions
of frontal lobe, cerebellum and temporal lobe was related to better working memory performance. Focusing on
the networks derived from ICA, our results integrated prefrontal regions and cerebellar regions through asso-
ciations with working memory and inattention symptoms, lending support for the theory of ‘cool’-cognition
dysfunction being mediated by inferior fronto-striato-cerebellar networks in ADHD. Siblings showed inter-
mediate cognitive impairments between patients and controls but presented GM anomalies in unique focal re-
gions, suggesting they are a separate group potentially aﬀected by the shared genetic and environmental risks
with ADHD patients.
1. Introduction
ADHD is a childhood-onset neuropsychiatric disorder characterized
by attentional problems, and/or hyperactivity and impulsivity, and can
seriously aﬀect patients' interpersonal and academic performance
(American Psychiatric Association, 2013). A meta-analysis of follow-up
studies has shown that in about 15% children with ADHD the disorder
persists into adulthood, and the persistence percentage increases to
65% if partially remitted patients are taken into account (Faraone et al.,
2006). In the general adult population, the average prevalence rate of
ADHD is about 2.5%–4.9% (Simon et al., 2009). This speciﬁc patient
group deserves increased attention from a clinical treatment viewpoint
as well as from the basic research community to understand the neu-
ropathology.
Adult ADHD abnormalities in cortical brain regions remain poorly
understood. While in structural magnetic resonance imaging (sMRI)
studies of childhood ADHD, signiﬁcant and relatively consistent brain
structure alterations have been reported in patients, including smaller
global brain volume than healthy controls (Castellanos et al., 1996;
Castellanos et al., 2002; Greven et al., 2015), gray matter (GM) re-
ductions in caudate nucleus (Frodl and Skokauskas, 2012; Nakao et al.,
2011), right globus pallidus and putamen (Ellison-Wright et al., 2008;
Frodl and Skokauskas, 2012), fronto-striatal-parietal pathway
(Dickstein et al., 2006; Filipek et al., 1997), and cerebellum (Valera
et al., 2007). In contrast, GM changes identiﬁed in adult ADHD were
inconsistent. A meta-analysis study conducted by Frodl and Skokauskas
highlighted GM reduction in anterior cingulate cortex (Frodl and
Skokauskas, 2012), while another meta-analysis study by Nakao et al.
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(2011) showed no group diﬀerence in regional networks. These ambi-
guities may be due to the limited sample size and methodological dif-
ferences of studies. Recently, Hoogman et al. (2017) investigated the
subcortical brain volumes with the largest sample size to date and re-
ported that nucleus accumbens, amygdala, caudate nucleus, hippo-
campus, and putamen showed reduced volume in ADHD with eﬀect
sizes decreasing from youth (< 15 years) to adults (> 21 years); in fact,
no signiﬁcant brain volume reductions were found for adult patients.
In addition to signiﬁcant functional deﬁcits in the two symptom
domains (i.e. inattention and hyperactivity/impulsiveness), ADHD pa-
tients also often present with impaired cognitive ability (American
Psychiatric Association, 2013). Children with ADHD have been docu-
mented with many aspects of neurocognitive dysfunction, including
executive function, working memory, inhibition, delay aversion, and
timing response (Martinussen et al., 2005; Sjowall et al., 2013). In
adults, cognitive impairments have also been observed (Mostert et al.,
2015), most consistently in executive function (Boonstra et al., 2005),
followed by long term memory (Skodzik et al., 2017), set-shifting
(Rohlf et al., 2012), inhibition (Fuermaier et al., 2015), and delayed
discounting (Marx et al., 2010), each aﬀecting a subset of patients
(Mostert et al., 2018). Neurocognitive dysfunctions in speciﬁc cognitive
domains along with the two distinct symptom domains suggest a high
phenotypic and etiologic heterogeneity in ADHD (Nigg et al., 2005).
Identifying and understanding the neuronal circuits underlying each
symptom domain and speciﬁc aspects of cognition would help us parse
the heterogeneity in ADHD.
Through integrating the deﬁcits in cognition, symptom and brain
structure, a systematic analysis on the interrelationship can provide us
with more information about how the persistence of ADHD manifests in
the brain resulting in impaired behavior and cognition. While a few
studies with smaller sample sizes have been conducted focusing on a
speciﬁc type of cognition or symptom domain in adult ADHD (Makris
et al., 2007; Makris et al., 2015), in this study, we leveraged data of
relatively large samples combined from the NeuroIMAGE project (von
Rhein et al., 2015) and the IMpACT Dutch consortium (Onnink et al.,
2014), including patients, unaﬀected siblings and controls. We em-
ployed both independent component analysis (ICA) (Xu et al., 2009)
and voxel-based morphometry analysis (VBM) (Good et al., 2001). ICA
groups covarying voxels, not limited to physically connected voxels,
into one component, and thus forms a network-based analysis. Brain
imaging data of participants included in this study have been previously
analyzed with focuses on GM diﬀerences in adult ADHD (Onnink et al.,
2014) or broad ADHD (including children and adults) (Bralten et al.,
2016; Hoogman et al., 2017). While Bralten et al. also investigated GM
regions related to symptom counts, where inattention and hyperactivity
symptoms were added together, cognition and individual symptom
domains (i.e. inattention or hyperactivity) have not been studied ex-
plicitly, and not with combined larger adult only samples. To shed light
on these unknowns, we aim to identify GM regions underlying working
memory and inhibition deﬁcits, as well as the two symptom domains of
ADHD. Given previous reports that unaﬀected siblings of ADHD pa-
tients also show brain abnormalities and cognitive impairments to an
extent (Bralten et al., 2016; Castellanos et al., 2003; Durston et al.,
2004; Faraone et al., 1993; Slaats-Willemse et al., 2003), we also in-
vestigated how unaﬀected siblings behave in cognitive function,
symptom domains, and associated neural correlates comparing with
patients and healthy controls.
2. Materials and methods
2.1. Participants
This study employed a large cohort of 486 European Caucasian
adults aggregated from two projects: 301 samples from the
NeuroIMAGE project (age range: [18, 30], female/male:127/174) (von
Rhein et al., 2015) and 185 samples from the Dutch chapter of the
IMpACT consortium (age range: [18, 63], female/male:136/49)
(Mostert et al., 2015; Onnink et al., 2014). Written informed consent
was obtained from all participants. The inclusion and exclusion criteria
were described in detail in the original papers (Mostert et al., 2015;
Onnink et al., 2014; von Rhein et al., 2015). In brief, adult ADHD pa-
tients were included if they met the DSM-IV (NeuroIMAGE project)
(American Psychiatric Association, 1994) or DSM-IV-TR (IMpACT
consortium) (American Psychiatric Association, 2000) criteria for adult
ADHD. In addition, IMpACT included ADHD diagnosis in childhood;
NeuroIMAGE, which is a longitudinal study, also required a formal and
research diagnosis in childhood. Unaﬀected siblings were enrolled from
NeuroIMAGE ADHD families, and healthy controls were recruited from
the families free of ADHD. For adult samples from the NeuroIMAGE
cohort, a total of 206 families were involved, including 124 in-
dependent participants, 71 two-member families, 11 three-or-four-
member families. The participants from the Dutch IMpACT cohort were
all independent. All participants had IQ≥ 70, no diagnosis of autism,
epilepsy, brain disorders and any genetic or medical disorders related to
externalizing behaviors which might be confused with ADHD (Onnink
et al., 2014; von Rhein et al., 2015). In NeuroIMAGE project, medicated
patients have received psychostimulant treatment (von Rhein et al.,
2015). In IMpACT project, medicated patients have received ADHD
medication (Hoogman et al., 2011). Medicated participants were re-
quired free of medication at least 48 h in NeuroIMAGE project (van
Lieshout et al., 2016) or 24 h in IMpACT project (Hoogman et al., 2011)
prior to assessments. One healthy control also reported to take psy-
chostimulant medication. The rationale of including both medicated
and medication-naive cases in this analysis can be summarized as fol-
lows: (1) About 50% of ADHD patients were medicated in our samples.
Including both patient groups increased the power to detect GM asso-
ciations with symptoms and cognition; and (2) Including both patient
groups helped us better parse the neural correlates of symptoms and
cognition in adult ADHD. As a result, we found that both medicated and
medication-naive cases showed signiﬁcantly higher symptoms and
worse cognition than healthy controls. Two symptom domains, in-
attention (IA) and hyperactivity/impulsivity (HI), were evaluated for
all participants consistently between two cohorts based on 18 DSM-IV
symptom questions. The ﬁnal symptom scores for both domains range
from 0 to 9 and the larger the score, the more severe the disorder.
Siblings had< 5 in either the inattention or hyperactivity/impulsive-
ness symptom score. Healthy controls were ﬁltered to have scores< 2
in either domain. Detailed demographics, symptom, comorbidity, and
MRI scanning sites of this study can be seen in Table 1.
2.2. Neurocognitive assessments
Two cognitive functions, working memory and inhibition, were
assessed in both projects. For working memory, the WAIS Digit Span
task (Wechsler et al., 2000) was employed for almost all participants
(N= 480) in both projects. Here we used maximum digit span forward
and backward as measures of working memory. For inhibition, the
NeuroIMAGE project employed a stop task for 202 participants with
stop-signal reaction time and the total number of commission and
omission error as outcome measures (Logan et al., 1984), while the
Dutch IMpACT project utilized a go/no-go task for 150 participants
with standard deviation of response time in go digits and standard
deviation of response time of commission errors as outcome measures
(Mostert et al., 2015). These variables were selected for each assess-
ment because they showed case-control diﬀerences (p < 0.05). Since
each assessment task measures diﬀerent aspects of inhibition, and the
variables cannot be simply combined. Thus, we treated them separately
in the association analysis.
2.3. Neuroimaging
T1-weighted MRI images were acquired with three 1.5 T scanners
K. Duan et al. NeuroImage: Clinical 19 (2018) 374–383
375
(NeuroIMAGE project using Siemens SONATA and Siemens AVANTO,
and IMpACT project in Dutch site using Siemens SONATA) with closely
matched settings, such as, a voxel size of 1× 1×1mm3, TI 1000ms,
TR 2730ms, TE 2.95ms, ﬁeld of view 256mm and 176 sagittal slices.
For NeuroIMAGE project, two sMRI scans were obtained for every
participant and their qualities were evaluated by two independent
raters on a 4-point scale (1= good; 2=useable; 3= poor; 4= very
poor) (von Rhein et al., 2015). Only those rated as good by Neuro-
IMAGE team were used for this analysis. For the Dutch IMpACT project,
sMRI scans were visually checked by the IMpACT team (Onnink et al.,
2016; Onnink et al., 2014; Wolfers et al., 2017), and selected scans were
used for this analysis. Then, all included sMRI scans were segmented
into six types of tissues using Statistical Parametric Mapping 12
(SPM12, http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm12/). GM
data were normalized to the Montreal Neurological Institute (MNI)
template, and modulated (to keep local GM volume information as we
are more interested in GM volume co-variation networks) and
smoothed with a 6× 6×6mm3 Gaussian kernel. In addition to sMRI
scan quality check by NeuroIMAGE and IMpACT teams, all included
GM images had to pass our quality check with a correlation higher than
0.8 with the mean gray matter image. A GM mask was applied to in-
clude voxels with mean gray matter volume larger than 0.2 resulting in
456,921 voxels. For each included voxel, the confounding eﬀects of age,
sex and site were corrected using a linear regression model, where the
regression coeﬃcients were estimated from data on controls only to
eliminate potential inﬂuences of diagnosis interactions with age or sex.
We further conﬁrmed that after correcting age, sex and site eﬀects, the
total GM volume did not diﬀer between the two cohorts (p= 0.71), and
adding the cohort as an additional variable into the analyses did not
change the signiﬁcance of the reported results (see Appendix A for
details). Therefore, we combined the imaging data from two cohorts to
increase the detection power in subsequent imaging analysis.
2.4. GM component decomposition and association analyses
The preprocessed GM data (dimension: subject× voxel) was de-
composed into 22 distinct components using ICA (Xu et al., 2009),
where the component number was estimated using the minimum de-
scription length algorithm (Rissanen, 1978) and ICA was implemented
with the infomax algorithm (Bell and Sejnowski, 1995) within the GIFT
toolbox (http://mialab.mrn.org/software/gift). Infomax decomposes
the preprocessed GM data into linear combinations of independent
components; i.e., preprocessed GM data (X)= loadings (A)× compo-
nents (S), where the independence among components is achieved by
maximizing the entropy of components. For extracted GM components
S (dimension: component× voxel), each row is an independent com-
ponent and represents a GM covariation network where highly
weighted voxels express very similar GM patterns. For the loading
matrix A (dimension: subject× component), each column is the
loading vector of the corresponding component presenting the weights
of this component across all subjects. To make sure the decomposition
is stable, ICASSO (Himberg et al., 2004) with 10 ICA runs was used to
generate stability indices for each component, where the stability index
equals 1 in the ideal case. The most stable run was selected as the ﬁnal
ICA decomposition.
Next, in order to identify GM components underlying cognition and
symptoms, associations between GM components and two symptom
domains, as well as working memory and inhibition performance were
tested using a linear mixed eﬀect model (model 1 in Table 2), where
family ID was used as a random eﬀect to control for relatedness (the
same for models 2–5), and other predictors (i.e. age, sex and GM
loading of a component) were treated as ﬁxed eﬀects. Signiﬁcance was
Table 1
Demographics of the study population.
Variables Diagnosis group (#)
Healthy control (176) Unaﬀected sibling (96) ADHD (214)
Medicated ADHD (105) Unmedicated ADHD (109)
Age 28.93 ± 11.79 21.41 ± 2.34 28.04 ± 9.56 22.76 ± 6.55
Sex (F/M) 125/51 47/49 56/49 35/74
Estimated IQ 108.19 ± 14.88 104.80 ± 15.75 105.50 ± 16.33 101.59 ± 17.05
Inattention (IA) 0.56 ± 1.24 1.60 ± 1.97 7.49 ± 1.52 7.01 ± 1.75
Hyperactivity/impulsiveness (HI) 0.70 ± 1.12 1.48 ± 1.65 5.92 ± 2.26 5.69 ± 2.48
Major depression 13 0 30 7
Anxiety disorder 4 1 17 3
Scan site 1
NeuroIMAGE 1
47 40 15 43
Scan site 2
NeuroIMAGE 2
32 56 20 48
Scan site 3
IMpACT (Dutch)
97 0 70 18
Note: Major depression and anxiety disorder were diagnosed consistently between two cohorts based on DSM-IV criteria (Onnink et al., 2014; von Rhein et al., 2015).
The full-scale IQ was estimated consistently between two cohorts based on Wechsler Adult Intelligence Scale III (Bralten et al., 2016; Mostert et al., 2015).
Table 2
Linear mixed eﬀect models used in the analysis.
Model Function Response Predictors
Fixed eﬀect Random eﬀect
Model 1 Test association Cognitive/symptom variable Age, sex, GM loading of a component Family ID
Model 2 Test group diﬀerence (4 groups) for GM loadings of a component GM loadings of a component Diagnosis (4 groups) Family ID
Model 3 Test group diﬀerence (4 groups) for cognition/symptom Cognition/symptom variable Age, sex, diagnosis (4 groups) Family ID
Model 4 Test group diﬀerence (3 groups) for GM loadings of a component GM loadings of a component Diagnosis (3 groups) Family ID
Model 5 Test medication eﬀect for GM loadings of a component GM loadings of cases of a component Medication status Family ID
Note: 4 groups included unmedicated cases, medicated cases, unaﬀected siblings and controls. 3 groups included cases, unaﬀected siblings and controls.
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corrected for multiple comparisons for all networks at a false discovery
rate (FDR) of 0.05. Then, the potential confounding eﬀects from med-
ication, comorbidity with major depression and anxiety, IQ as well as
cohort were examined by adding them as covariates into the model 1
(Table 2) separately to evaluate their impact on the signiﬁcance of
associations, in which medication and comorbidity were treated as
binary variables. Moreover, pairwise group diﬀerence among medi-
cated cases, medication-naïve cases, healthy controls and unaﬀected
siblings were tested for the GM loadings of identiﬁed components, and
associated cognitive function and symptom severity using models 2 and
3 in Table 2, respectively.
Finally, we also tested GM components for ADHD diﬀerences re-
gardless of their association with cognition or symptom severity using
GM loadings of patients and controls only, which was tested by model 4
in Table 2, and multiple comparisons were corrected at FDR p < 0.05.
Subsequently, medication eﬀects were tested on GM loadings of pa-
tients only using model 5 in Table 2, where medication status was
treated as a ﬁxed eﬀect. Potential confounding eﬀects of comorbidity
and IQ as well as cohort were also tested for these components by
adding them as covariates into the model 4 (Table 2) separately. In
addition, the diﬀerences of GM loading of siblings compared with those
of ADHD patients and healthy controls were also examined using model
4 in Table 2.
2.5. VBM analysis
In order to validate ICA results to an extent, we also employed the
VBM analysis on the same preprocessed GM data. To identify GM re-
gions underlying cognition or symptom, we performed similar linear
mixed eﬀect model as listed in Table 2 model 1 with substituting GM
loadings of a component with GM volumes of voxels. Multiple com-
parison correction FDR p < 0.05 was applied. Similarly, ADHD dif-
ferences were tested on voxels of healthy controls and ADHD patients
by model 4 in Table 2 with the response variable as GM volumes of
voxels, and FDR p < 0.05 was utilized. The extent threshold was set at
10 voxels to include almost all identiﬁed regions except for isolated
voxels.
3. Results
3.1. ICA results
By decomposing the GM data of 486 adults including 214 ADHD
patients, 96 unaﬀected siblings and 176 healthy controls (detailed de-
mographics information see Table 1), 22 distinct GM components were
generated and their ICASSO stability indices were all larger than 0.97.
Out of 22 GM components extracted by the most stable ICA run, four
GM components were signiﬁcantly related to either working memory or
inattention symptom severity measures. The stability index, related
phenotype (i.e. working memory or symptom domain or ADHD status),
brain regions of each component (regions were thresholded by Z-score
of 2.5 and cluster volume larger than 1 cm3), and peak voxel co-
ordinates are listed in Table 3 (ICs 1–4) and also plotted in Fig. 1.
GM loadings of both component 1 (inferior semilunar lobule: p_as-
sociation=1.38×10−4, t (476)= 3.84, variance explained
(VE)= 3.08%) and component 2 (inferior frontal gyrus: p_associa-
tion=2.68×10−3, t (476)= 3.02, VE= 1.90%) presented signiﬁcant
positive associations with forward digit span performance. GM loadings
of both component 2 (inferior frontal gyrus: p_associa-
tion=3.95×10−3, t (476)= 2.90, VE=1.73%) and component 3
(superior and middle frontal gyri: p_association= 1.66× 10−3, t
(476)= 3.16, VE= 2.05%) showed signiﬁcant positive relations with
backward digit span performance. GM loadings of component 4 were
signiﬁcantly and negatively associated with IA score (cerebellar tonsil
and culmen: p_association= 2.26× 10−3, t (462)=−3.07,
VE=1.88%). No signiﬁcant confounding eﬀects of medication,
comorbidity, IQ or cohort were found for these associations. We did not
observe any signiﬁcant associations of GM components with inhibition
and hyperactivity/impulsiveness.
Fig. 2 shows pairwise comparisons for digit span performances
(forward and backward) and IA symptom as well as associated four GM
components (ICs) among medicated cases, medication-naïve cases,
siblings and controls (p < 0.05 was used for statistical signiﬁcance). As
plotted in Fig. 2(a), patients, both medicated and unmedicated, showed
signiﬁcantly worse working memory performance compared to con-
trols, while siblings presented in-between performances with no sig-
niﬁcant diﬀerence from either of the other groups in forward digit span
task but with signiﬁcant worse performance compared to controls in
backward digit span task. For IA, four groups were signiﬁcantly dif-
ferent from each other with medicated cases showing the most severe
symptoms, followed by medication-naïve cases, siblings and then
healthy controls. In Fig. 2(b), all GM loadings are normalized scores
with standard deviations around 1 and thus are much larger than the
mean values. GM reduction in patients compared to controls was found
in components 1 (medicated cases vs. controls: p= 1.06×10−2, t
(279)=−2.57), 2 (unmedicated cases vs. controls: p= 1.01× 10−2, t
(283)=−2.59) and 4 (medicated cases vs. controls: p= 1.06×10−2,
t (279)=−2.57, unmedicated cases vs. controls: p= 4.56×10−2, t
(283)=−2.01). Even though there were some diﬀerences between test
results of medicated cases and unmedicated cases in comparison to
controls for components 1, 2 and 4, no signiﬁcant group diﬀerences
were observed between medicated and unmedicated cases for any of the
four GM components. Siblings did not show any signiﬁcant diﬀerence
from controls, but diﬀered from patients in components 1 (medicated)
and 2 (unmedicated). In component 4, siblings presented GM volume
values in-between cases and controls, but did not signiﬁcantly diﬀer
from either group. No GM diﬀerences were observed in component 3
for any groups.
In the case-control comparison, component 5, located in the middle
frontal gyri as listed in Table 3 (IC 5) and shown in Fig. 3, was identiﬁed
showing signiﬁcant GM anomalies. A signiﬁcant medication eﬀect was
observed for component 5, and after regressing out the medication ef-
fect, the GM loadings still showed signiﬁcant reduction in patients as
shown in Fig. 4 (Cohen's d [95% CI]=−0.78 [−0.98, −0.57];
p= 5.56×10−6, t (387)= 4.61). Siblings also presented signiﬁcantly
diﬀerent GM loadings compared to controls in component 5
(p= 1.93× 10−6, t (269)= 4.87). Potential GM abnormalities were
also observed in two additional interesting components encompassing
cingulate, occipital gyri, though they did not pass FDR correction (de-
noted as components 6 and 7 in Appendix E). No comorbidity, IQ or
cohort eﬀects were found for these GM alterations.
Most of the identiﬁed GM components associated with working
memory and ADHD status were replicated when running ICA on two
cohorts separately (see Appendix C for details). And the identiﬁed as-
sociations held to a large extent with less signiﬁcance in female and
male participants, separately. (see Appendix G for details). We also ran
ICA on independent subjects only (i.e. excluding the 95 relatives), and
conﬁrmed that both the ICA decomposition and association pairs were
largely kept (see Appendix D for details).
3.2. VBM results
Fig. 5 plotted regions (FDR corrected at p < 0.05; cluster size
threshold k=10) showing signiﬁcant associations with working
memory task performance or ADHD diagnosis (all regions were listed in
Appendix F). No voxels were signiﬁcantly associated with inhibition or
symptom domains. Multiple regions in frontal lobe, temporal lobe, and
cerebellum in subplot A were signiﬁcantly and positively correlated
with forward digit span performance, and regions in frontal lobe in
subplot B were signiﬁcantly and positively associated with backward
digit span performance. Subplot C presents regions in cingulate gyrus
showing a signiﬁcant GM reduction in ADHD patients.
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4. Discussion
In this study, we investigated the neural correlates of cognitive
deﬁcits, symptom domains and ADHD status in adult ADHD patients,
their unaﬀected siblings and controls. From ICA analysis, we identiﬁed
three GM components associated with working memory involving su-
perior, middle and inferior frontal gyri, and inferior semilunar lobule,
one GM component associated with IA symptoms involving cerebellar
tonsil and culmen and one GM component associated with case-control
status, including the middle frontal gyri. From the VBM analysis,
multiple regions correlated to working memory performance involving
frontal lobe, cerebellum, superior and middle temporal gyri, which are
largely overlapped with ICA components associated with working
memory. A small area in middle cingulate presented GM reduction in
ADHD patients. No signiﬁcant GM components or VBM regions un-
derlying response inhibition and hyperactivity/impulsivity were ob-
served for both methods.
Both VBM identiﬁed brain regions and ICA components highlighted
frontal lobe and cerebellum being associated with working memory
performance, even though VBM reported many sparse and small regions
across the brain, while ICA extracted several coherent networks (small
and separate regions were ignored). Moreover, ADHD patients showed
GM reduction in cingulate in both methods (marginal signiﬁcance for
ICA analysis, see Appendix E, Fig. E1, IC 6). ICA also extracted one
component associated with inattention symptom (Fig. 1, IC4), and one
component associated with ADHD status (Fig. 3, IC5), while in VBM
analysis the corresponding regions did not pass FDR correction. The
discrepancy likely highlights the beneﬁt of network-based analyses.
VBM identiﬁed a relatively larger region in the temporal lobe under-
lying working memory (Appendix F, A subplot) than ICA (volume <
1 cm3 not reported), which may indicate that only a small part of
temporal gyrus shared a covariation pattern with frontal lobe and
cerebellum so that ICA grouped them into one component. Overall, we
observed high correspondence between ICA and VBM analyses, and ICA
provided more organized network-based results, therefore the following
discussion is based on ICA results.
Table 3
Stability indices, related phenotype, Talairach labels, peak voxel coordinates and volume of GM components 1–5 (|Z| > 2.5, volume > 1 cm3).
IC: stability index Related phenotype Brain region L/R volume (cm3) L/R: max Z (x, y, z)
IC1: 0.98 FW (+) Inferior semilunar lobule (+)
Tuber (+)
1.2/1.3
1.0/1.0
7.8 (−22, −84, −36)/7.8 (21, −85, −35)
8.5 (−19, −89, −29)/8.2 (18, −88, −30)
IC2: 0.99 FW (+) BW (+) Inferior frontal gyrus (+)
Inferior frontal gyrus (−)
1.3/1.4
1.2/0.9
4.8 (−30, 15, −22)/5.7 (22, 12, −22)
6.6 (−21, 22, −15)/4.9 (24, 24, −13)
IC3: 0.99 BW (+) Superior frontal gyrus (+)
Middle frontal gyrus (+)
3.2/3.0
2.2/2.0
7.2 (−22, 60, −16)/6.4 (21, 59, −18)
6.4 (−36, 57, −12)/5.5 (37, 57, −13)
IC4: 0.99 IA (−) Cerebellar tonsil (+)
Culmen (+)
Tuber (+)
2.2/1.9
1.3/0.8
1.0/0.7
9.4 (−48, −49, −37)/8.1 (45, −44, −36)
8.9 (−48, −45, −29)/6.5 (48, −45, −29)
8.9 (−52, −54, −30)/6.4 (52, −50, −30)
IC5: 0.98 ADHD status (−) Middle frontal gyrus (+)
Middle frontal gyrus (−)
1.8/1.9
1.1/1.3
9.9 (−33, 27, 26)/11.0 (34, 22, 32)
8.6 (−24, 18, 39)/9.7 (25, 19, 38)
Note: IC denotes the component. The ‘+’ or ‘−’ sign in the Related phenotype column indicates that GM volume of the component is positively or negatively related
to the cognition performance, symptom or diagnosis. The ‘+’ or ‘−’ sign in the Brain region column indicates positive or negative contribution to this component
from the regions, which are mapped to red colored or blue colored regions in the component spatial map, respectively. FW, BW and IA denote forward digit span
performance, backward digit span performance and inattention symptom severity. For ADHD status, ADHD was coded as 1 and control was coded as 0.
Fig. 1. Four signiﬁcant GM components (ICs) associated with either working memory or inattention symptoms (|Z| > 2.5). GM loadings of IC1 in inferior semilunar
lobule were positively related to forward digit span performance. GM loadings of IC2 in inferior frontal gyrus were positively associated with both forward and
backward digit span performance. GM loadings of IC3 in superior and middle frontal gyri were positively related to backward digit span performance. GM loadings of
IC4 encompassing cerebellar tonsil, culmen and tuber were negatively associated with inattention symptom severity. (For interpretation of the references to color in
this ﬁgure, the reader is referred to the web version of this article.)
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NeuroIMAGE and IMpACT used diﬀerent assessment tasks for in-
hibition which (together with the resultant drop in sample size) may be
partially responsible for no signiﬁcant results. The absence of associa-
tion for hyperactivity/impulsivity may be due to its decline with age
(Spencer et al., 2007) as explained later on. GM components 1, 3, and 4,
included outward cortical regions, which are known to be susceptible to
scanning eﬀects or motion. We double checked their correlation with
scanning sites in the control group and conﬁrmed no signiﬁcant scan-
ning eﬀects. Furthermore, we compared them with typical scanning
parameters-related GM components reported in Chen's paper (Chen
et al., 2014), of which the scanning related ‘edge’ components cover
outward region of multiple lobes forming a ring shape. The GM com-
ponents we observed here were more focal regions, and the thin layer of
cortical regions likely reﬂects the more precise and thin cortex seg-
mentation from SPM12. Regarding the likelihood of motion artifacts,
we did several examinations on the original data and subgroup data to
guard against false discoveries (see Appendix B), even though no direct
motion measures were available.
The three GM components (ICs 1–3, Fig. 1) were related sig-
niﬁcantly to either forward or backward digit span performance, and
two of them (ICs 2 and 3, Fig. 1) were in fact related to both if a
nominal p value (p < 0.05, data not shown) was applied, enhancing
their overall relevance to working memory. The regions highlighted in
our results, superior, middle, and inferior frontal cortex, have been
repeatedly associated with working memory by brain functional MRI
studies (Brodziak et al., 2013; Narayanan et al., 2005; Pessoa et al.,
2002), and recent subdural electrocorticographic neural signals (Cogan
et al., 2017). In contrast, evidence of brain structural variation under-
lying the variability of working memory capacity is very limited, but
also points to prefrontal regions. For instance, the cortical surface in
Fig. 2. Group comparisons in working memory, inattention symptom, and associated GM components (ICs). One star, two stars and three stars indicate signiﬁcant
group diﬀerences at 0.005 < p < 0.05, 0.0005 < p < 0.005 and p < 0.0005, respectively. FW, BW and IA in (a) and (b) stand for forward and backward digit
span performance and inattention symptom severity, respectively. The total whisker length in (a) represents two standard deviations (STD). The STD in (b) range
from 0.86 to 1.18, therefore they were not plotted here. Colors indicate medicated cases (Medicated), unmedicated cases (Unmedicated), siblings (SIB) and healthy
controls (Control). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. One additional GM component (IC5 in middle frontal region) showing
signiﬁcant case-control diﬀerences (|Z| > 2.5). GM decrease was observed in
the middle frontal gyrus colored in red and GM increase was observed in a
smaller adjacent region colored in blue for ADHD patients. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
Fig. 4. Group diﬀerences of the GM component 5 (IC5). Three stars represent
signiﬁcant group diﬀerence at p < 0.0005. The loading standard deviation
(STD) of component 5 ranges from 0.82 to 1.14. Colors indicated patients
(Case), siblings (SIB) and healthy controls (Control). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web ver-
sion of this article.)
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right inferior and superior frontal gyri has demonstrated a signiﬁcant
positive association with working memory performance in healthy
older subjects (Nissim et al., 2016). Speciﬁc to adult ADHD, GM re-
duction has been found in inferior frontal gyrus compared to healthy
controls (Depue et al., 2010; Pironti et al., 2014) and related to cog-
nitive deﬁcits of patients, including response inhibition (Depue et al.,
2010) and sustained attention (Pironti et al., 2014). Extending to pre-
vious studies, we observed that worse working memory performance
was associated with lower GM volume in the superior, middle, and
inferior frontal areas (red regions in Fig. 1, ICs 2 and 3), where patients
had decreased GM volume compared to controls, though not the most
signiﬁcant GM reduction across whole brain.
Another GM component positively associated with working memory
was present in the inferior semilunar lobule (IC1, Fig. 1). Baier and
colleagues studied patients with cerebellar ischemic stroke and found
that lesions in inferior semilunar lobule, tonsil, and vermal pyramid
speciﬁcally impaired working memory performance when the to-be-
remembered targets were presented together with task-irrelevant items
(Baier et al., 2014). More similar to our ﬁndings are the published
observations that GM volume in inferior semilunar lobule was sig-
niﬁcantly positively associated with working memory performance
during development (Moore et al., 2017) and in adulthood (Ding et al.,
2012). Furthermore, GM reduction in right inferior semilunar lobule
(right Crus II) has been documented in ADHD patients both in child-
hood (Ivanov et al., 2014) and adulthood (del Campo et al., 2013), in
line with our observation of lower GM volume in patients. Together, the
associated GM components in prefrontal and inferior semilunar regions
provide additional support for the idea that the fronto-striato-cerebellar
circuitry serves working memory function (Giedd et al., 2001), and
their GM abnormality might underline the ‘cool’-cognition dysfunction
in ADHD patients (Rubia, 2011).
Interestingly, another cerebellar component (IC4, Fig. 1) in tonsil
and culmen was related to IA, reinforcing the role of cerebellum in
cognition. Speciﬁc to culmen and cerebellar tonsil, induced activation
by sustained attention has been reported in healthy adults and ADHD
patients (Lawrence et al., 2003; Norman et al., 2017), and symptom
severity in ADHD patients was negatively correlated to cerebellar
activation including posterior lobe and cerebellar tonsil (Cubillo et al.,
2011; Norman et al., 2017). Our results further delineate that it is IA,
not hyperactivity/impulsivity, which is signiﬁcantly aﬀected by al-
terations in this cerebellar network in adult ADHD patients. GM re-
duction in this region in adult ADHD patients has been frequently re-
ported (del Campo et al., 2013; Seidman et al., 2011), which is
consistent with our ﬁndings. The fact that we did not ﬁnd any asso-
ciations with hyperactivity/impulsivity agrees with previous observa-
tions showing that in individuals with ADHD hyperactivity/impulsivity
declines with age, while attentional impairments remain (Spencer et al.,
2007).
In addition to the 4 components related to either working memory
performance or inattention symptoms, component 5, associated with
case-control status, including the middle frontal gyri, demonstrated
signiﬁcant GM abnormalities in patients with the largest eﬀect size (i.e.
the largest Cohen's d value), conﬁrming a previous report showing GM
reduction in middle frontal gyrus in adult ADHD patients (Seidman
et al., 2011). Additional two components (cingulate and occipital
components in Appendix E, Fig. E1), though not passing multiple
comparison correction, showed strikingly consistent ADHD anomalies
with previous reports, where GM reductions in anterior cingulate in
adult ADHD patients have been documented (Frodl and Skokauskas,
2012; Seidman et al., 2006), along with decreased cortical thickness in
left posterior cingulate gyrus (Makris et al., 2007), and GM increase in
occipital gyrus and cuneus (Pirontia et al., 2014; Seidman et al., 2011).
Regarding the functional impact of such GM abnormities, future in-
vestigations with measures from more aspects of cognition in ADHD are
needed.
A further break-down of participants into four groups, as shown in
Fig. 2, provided additional insights into the interrelationship among
cases, siblings, and controls. Consistent with previous studies (Alderson
et al., 2013; Mostert et al., 2015), our patients presented signiﬁcant
cognitive impairment in working memory. This result (in general)
propagated into associated GM components, where GM reduction was
observed for patients and independent of medication eﬀects. Interest-
ingly, ADHD-unaﬀected siblings, who have demonstrated some level of
lower performance, particularly in backward digit span task, did not
Fig. 5. Results of VBM analysis (FDR corrected at p < 0.05; k > 10). Colors are coded for association coeﬃcients. GM volume in regions in subplot A showed a
signiﬁcantly positive correlation with forward digit span performance, GM volume in regions in subplot B was signiﬁcantly and positively associated with backward
digit span performance. GM volume in subplot C in middle cingulate showed a signiﬁcant GM reduction in ADHD patients. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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show GM reduction in the associated components, and instead pre-
sented GM similar to that of controls, suggesting other brain regions
involved in cognition may be responsible for such lower performance in
the siblings. This speculation is strengthened by the middle frontal gyri
component (IC5, Fig. 5), where GM loadings in siblings were sig-
niﬁcantly diﬀerent from those of controls, but not patients. For IA
symptoms, all four groups signiﬁcantly diﬀered from each other.
Medicated patients showed the most severe symptoms, indicating this
group carried the most prominent attention deﬁcits. Siblings clearly
presented themselves as an intermediate group (i.e. based on the data
they could not be categorized into either controls or cases). In line with
IA symptoms, the cerebellar tonsil and culmen component (component
4) reﬂected four distinct groups (even though some diﬀerences were
not signiﬁcant (p > 0.05)). Overall, siblings presented intermediate
cognition/behavioral impairments between patients and controls, and
also GM anomalies in selected focal regions, suggesting they are a se-
parate group potentially aﬀected by the shared genetic and environ-
mental risk factors with cases (Bralten et al., 2016).
It is noteworthy that GM volume in a relatively smaller area in the
inferior frontal cortex (blue regions in Fig. 1, IC2) was negatively as-
sociated with working memory performance, where patients showed
higher GM volume than controls. This result, along with the GM volume
increase in a smaller part of middle frontal gyrus (blue regions in Fig. 3,
IC5), occipital gyrus and cuneus (Appendix E, Fig. E1, IC7) in patients,
is hard to explain. Previous studies have documented increased gray
matter volume in ADHD patients in the occipital region (Nakao et al.,
2011; Pironti et al., 2014). A possible explanation may be ineﬃcient
pruning/thinning processes during the development (Duerden et al.,
2012; Pironti et al., 2014). Additionally, we noticed that GM volume
increases were located at the boundaries between gray and white
matter, near the white matter tracks, compared to GM reduction re-
gions in patients. We speculate that the increased GM volume might
rather reﬂect decreased white matter volume of the same area. Further
veriﬁcation is warranted.
Interestingly, subcortical regions such as caudate and putamen
consistently implicated in children ADHD did not show any associations
with cognitive deﬁcits or disease related diﬀerences in adult ADHD.
This result supports the uprising view of delayed maturation in sub-
cortical regions in ADHD patients (Hoogman et al., 2017), thus leading
to no signiﬁcant eﬀects in adult patients, while the frontal-cerebellum
regions remain altered in adulthood for patients, linking to the persis-
tent cognitive deﬁcits and symptoms.
The ﬁndings presented here should be considered in the context of
several strengths and limitations. This study made use of sMRI data of
adults from the Dutch NeuroIMAGE and IMpACT cohorts, which
beneﬁted us with enhanced detection power, while the unbalanced
distributions of age, sex, as well as case-sibling-control ratio between
two cohorts might bias our results. We have done several exercises to
mitigate the potential cohort eﬀect, including the preprocessing ana-
lysis of correcting age, sex and scanning site eﬀects and post-hoc ana-
lysis by considering cohort as a covariate. Given no straightforward
motion measurements available, we did several examinations on the
original data quality and association retests on the subgroup of controls
only to eliminate the likelihood of identiﬁed components being motion
artifacts. Due to the inconsistency of inhibition measurements between
two cohorts and smaller sample size for each measure, we have limited
power to identify GM components signiﬁcantly related to inhibition
measures.
In summary, our results demonstrate that with a relatively large
sample size, GM abnormalities underlying working memory and in-
attention symptoms can be observed in adult ADHD patients in loca-
lized prefrontal and cerebellar regions. Our results ﬁt nicely into the
theory of ‘cool’-cognition dysfunction mediated by inferior fronto-
striato-cerebellar network in ADHD (Rubia, 2011). We did not observe
any subcortical regions associated with adult ADHD. This is consistent
with the results of a recent mega-analysis showing that subcortical
abnormalities present in children are no longer seen in adults with
ADHD (Hoogman et al., 2017). Siblings of ADHD patients showed sig-
niﬁcant diﬀerences in symptoms and working memory and had unique
GM regions associations to those compared to either patients or healthy
controls, suggesting they present a separate group potentially inﬂu-
enced by the shared genetic and environmental risks with ADHD
(Bralten et al., 2016).
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